AI Terminal
Elanix Biotechnologies AG
Declaration of Voting Results & Voting Rights Announcements • Dec 21, 2015
136_dva_2015-12-21_8b5aae50-49a2-44dd-9984-d4fd6ab1de8a.html
Declaration of Voting Results & Voting Rights Announcements
Open in ViewerOpens in native device viewer
News Details
Voting Rights Announcements | 21 December 2015 15:09
Elanix Biotechnologies AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
DGAP Voting Rights Announcement: Elanix Biotechnologies AG
2015-12-21 / 15:09
Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Correction of a notification of Major Holding published on 17.12.2015
1. Details of issuerElanix Biotechnologies AG
Fritz-Vomfelde-Straße 34
40547 Düsseldorf
Germany
2. Reason for notification
| Acquisition/disposal of shares with voting rights | |
| Acquisition/disposal of instruments | |
| X | Change of breakdown of voting rights |
| Other reason: |
3. Details of person subject to the notification obligation
| Name: | City and country of registered office: |
| Exchange Investors N.V. | Amsterdam Netherlands |
4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
5. Date on which threshold was crossed or reached09.12.2015
6. Total positions
| % of voting rights attached to shares (total of 7.a.) |
% of voting rights through instruments (total of 7.b.1 + 7.b.2) |
total of both in % (7.a. + 7.b.) |
total number of voting rights of issuer | |
| Resulting situation | % | 1,94 % | 1,94 % | 5166000 |
| Previous notification | 0,97 % | % | % | / |
7. Notified details of the resulting situation
a. Voting rights attached to shares (Sec.s 21, 22 WpHG)
| ISIN | absolute | in % | ||
| direct (Sec. 21 WpHG) |
indirect (Sec. 22 WpHG) |
direct (Sec. 21 WpHG) |
indirect (Sec. 22 WpHG) |
|
| DE000A0WMJQ4 | 0 | 0 | 0,00 % | 0,00 % |
| Total | 0 | 0,00 % |
b.1. Instruments according to Sec. 25 Abs. 1 Nr. 1 WpHG
| Type of instrument | Expiration or maturity date | Exercise or conversion period | Voting rights absolute | Voting rights in % |
| Rückforderungsanspruch Wertpapierdarlehen | 100000 | 1,94 % | ||
| Total | 100000 | 1,94 % |
b.2. Instruments according to Sec. 25 Abs. 1 Nr. 2 WpHG
| Type of instrument | Expiration or maturity date | Exercise or conversion period | Cash or physical settlement | Voting rights absolute | Voting rights in % |
| % | |||||
| Total | % |
8. Information in relation to the person subject to the notification obligation
| X | Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.). |
| Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: |
| Name | % of voting rights (if at least held 3% or more) | % of voting rights through instruments (if at least held 5% or more) | Total of both (if at least held 5% or more) |
9. In case of proxy voting according to § 22 Abs. 3 WpHG
| Date of general meeting: | |
| Holding position after general meeting: | % (equals voting rights) |
2015-12-21 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
| Language: | English |
| Company: | Elanix Biotechnologies AG |
| Fritz-Vomfelde-Straße 34 | |
| 40547 Düsseldorf | |
| Germany | |
| End of News | DGAP News Service |